About MAXITROL® (neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension) 3.5mg/10,000 units/0.1% ...

Expands and Strengthens Portfolio of Product Offerings for U.S. Ophthalmic Surgical and Acute Care Markets Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced ...

Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic‑focused healthcare company, today announced its acquisition of the exclusive U.S. commercialization rights of four FDA-approved ophthalmic ...